Key result
Persistence of pericardial effusion on serial echocardiograms in patients with pulmonary arterial hypertension was an independent predictor of worse survival (P<0.01).
Why the study?
Does the persistence of pericardial effusion on serial echocardiograms predict worse survival in patients with pulmonary arterial hypertension?
Cohort (n=200)
No
Does the persistence of pericardial effusion on serial echocardiograms predict worse survival in patients with pulmonary arterial hypertension?
p-value: p=<0.01
Persistence of pericardial effusion on serial echocardiograms in patients with pulmonary arterial hypertension is an independent predictor of mortality, highlighting its value in ongoing risk stratification.
No takes yet. Share an insight, caveat, or question.
May support serial echo monitoring for PAH risk stratification; leaves open whether effusion resolution modifies survival.
Batal et al. (2015) conducted a cohort in Pulmonary arterial hypertension (n=200). Persistence of pericardial effusion vs. Absence or resolution of pericardial effusion was evaluated on Survival (p=<0.01). Persistence of pericardial effusion on serial echocardiograms in patients with pulmonary arterial hypertension was an independent predictor of worse survival (P<0.01).